Timothy A. Chan, M.D., Ph.D.
Dr. Chan is a member of Memorial Sloan-Kettering Cancer Center’s central nervous system disease-management team and of the Brain Tumor Center. He is a board certified radiation oncologist specializing in the use of stereotactic radiosurgery, intensity modulated radiation therapy and conformal radiation therapy. In addition to treating patients, Dr. Chan is a Principal Investigator at a cancer genetics laboratory in the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that will improve the care of cancer patients.
Hans-Guido Wendel, M.D.
Dr. Wendel is a Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that will improve the care of cancer patients. His research is focused on modeling relevant genetic changes found in human cancer specimens in cell culture and in accurate mouse models, in particular, using the technique of adoptive transfer of retrovirally transduced hematopoietic stem cells.
Vundavalli V. Murty, Ph.D.
Dr. Murty is currently Director of the Cancer Cytogenetic Laboratory and Molecular Pathology at Columbia University. He is an Associate Editor of the journal Molecular Cancer and a Diplomate of the American Board of medical Genetics in the subspecialty, Clinical Cytogenetics. Dr. Murty has authored over 100 original research papers, book chapters, and reviews covering human and murine cancers. Dr. Murty’s laboratory investigates the genetic mechanisms involved in testicular germ cell tumor and cervical cancer.
Charles M. Rudin, M.D., Ph.D.
Dr. Charles Rudin is the Chief of the Thoracic Oncology Service at Memorial Slone Kettering Cancer Center specializing in the care of patients with lung cancer. Dr. Rudin directs both laboratory-based and clinical research with the goal of improving the outcome for patients with lung cancer. In addition to serving as Chief of the Thoracic Oncology Service at MSKCC, Dr. Rudin co-chairs the Eastern Cooperative Oncology Group Thoracic Committee and is a member of the National Cancer Institute Thoracic Malignancies Steering Committee.